跳至主要内容
临床试验/NCT04451395
NCT04451395已完成不适用

Investigating Pathways Between Maternal Nutritional Status, Breastmilk Composition, and Infant Linear Growth in Rural Pakistan

Aga Khan University1 个研究点 分布在 1 个国家目标入组 196 人开始时间: 2020年8月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
196
试验地点
1
主要终点
Maternal BMI

研究概览

简要总结

Breastmilk is considered optimal for infant growth and development. However, evidence suggests that breastmilk composition can vary according to maternal nutritional status. Among women in Pakistan, there is a high burden of undernutrition and micronutrient deficiencies. As well, the prevalence of early stunting among Pakistani infants is high. Using a hypothesized pathway model, this study will assess pathways between maternal nutritional status, breastmilk composition, and infant linear growth. This is a substudy to the Matiari emPowerment and Preconception Supplementation (MaPPS) Trial (ClinicalTrials.gov Identifier: NCT03287882).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
15 Years 至 25 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Enrolled in the MaPPS Trial
  • Mothers must report practicing exclusive or predominant breastfeeding (i.e., breastmilk only or breastmilk and non-nutritive feeds only)
  • The infant must be term-born (>37 weeks gestation)
  • Infant must be 3 months ± 30 days old at the time of recruitment
  • Mothers must be willing to provide a complete breastmilk expression from one breast
  • Intervention arm only: mother reports compliance with study-administered MMN supplements at least 50% of the time (i.e., 4 out of 7 days per week)
  • Able to provide informed consent

排除标准

  • Mother reports mixed feeding in her infant with nutritive feeds (i.e., any provision of formula or animal milk)
  • The infant was born preterm (earlier than 37 weeks gestation)
  • Mother does not wish to provide a complete breast expression of one breast
  • Intervention arm: mother reports compliance with MMN supplements <50% of the time

研究组 & 干预措施

Multiple micronutrients (UNIMMAP composition)

Experimental

The intervention is an oral tablet containing 15 different vitamins and minerals at the UNIMMAP composition (includes 30 mg iron, 400 μg folic acid, 15 mg zinc, 2 mg copper, 65 μg selenium, 800 μg RE vitamin A, 1.4 mg vitamin B1, 1.4 mg vitamin B2, 18 mg niacin, 1.9 mg vitamin B6, 2.6 μg vitamin B12, 70 mg vitamin C, 5 μg vitamin D, 10 mg vitamin E and 150 μg iodine). Each tablet is small (approximately 10 mm diameter) and has been procured using the UNICEF supply catalogue. A single MMN supplementation dose will consist of a single tablet..The supplement is provided within the parent trial.

Other Name: UNICEF, Micronutrient tabs, pregnancy/PAC-1000

干预措施: Multiple micronutrients (UNIMMAP composition) (Dietary Supplement)

Standard of care

No Intervention

Daily iron and folic acid supplementation provided through the existing public health system.

结局指标

主要结局

Maternal BMI

时间窗: 3 months postpartum

Maternal dietary diversity score

时间窗: 3 months postpartum

Minimum score: 0, maximum score: 10

Maternal hemoglobin concentration

时间窗: 3 months postpartum

Maternal supplement adherence

时间窗: 3 months postpartum

Determined by report (options: 0, 25, 50, 75, or 100%)

Breastmilk macronutrient composition

时间窗: 3 months postpartum

Breastmilk micronutrient composition

时间窗: 3 months postpartum

Infant length

时间窗: 3 months postpartum

次要结局

  • Breastmilk microbiome(3 months postpartum)
  • Infant microbiome(3 months postpartum)
  • Infant weight(3 months postpartum)
  • Infant middle-upper arm circumference(3 months postpartum)
  • Infant head circumference(3 months postpartum)
  • Breastmilk bioactive composition(3 months postpartum)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Zulfiqar Ahmed Bhutta

Founding Chair, Centre of Excellence in Women and Child Health

Aga Khan University

研究点 (1)

Loading locations...

相似试验